MedTrace Logo

Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time

NCT00245791 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-06-03

No results posted yet for this study

Summary

The purpose of the study is to compare the safety and effectiveness of the antibiotic levofloxacin by administering a higher dose of levofloxacin and using a shorter course of therapy.

Conditions

  • Complicated Urinary Infection

Interventions

DRUG

Levofloxacin

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Lindsay E Nicolle, MD, FRCPC · University of Manitoba

  • Godfrey KP Harding, MD, FRCPC · University of Manitoba

  • George G Zhanel, PhD, FCCP · University of Manitoba

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Completion
2005-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00245791 on ClinicalTrials.gov